These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 13925361)

  • 1. [The enzyme inhibitor Trasylol in experimental shock caused by scalding in rats. Comparison with the ganglionic blocking agent Ecolid].
    VERAGUT UP
    Helv Chir Acta; 1962 Apr; 29():144-51. PubMed ID: 13925361
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental studies on the effect of a ganglion-blocking drug (Ecolid) on chronic cor pulmonale].
    HUTAS I; MIHOCZY L
    Magy Belorv Arch (1955); 1961 May; 14():76-8. PubMed ID: 13717033
    [No Abstract]   [Full Text] [Related]  

  • 3. Electrophysiological investigation of chlorisondamine dimethochloride (Ecolid T.M.) a new ganglionic blocking agent.
    SCHNEIDER JA; MOORE RF
    Proc Soc Exp Biol Med; 1955 Jul; 89(3):450-3. PubMed ID: 13254791
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies with the ganglionic blocking agent, chlorisondamine chloride in unanesthetized and anesthetized dogs.
    MAXWELL RA; PLUMMER AJ; OSBORNE MW
    Circ Res; 1956 May; 4(3):276-81. PubMed ID: 13317018
    [No Abstract]   [Full Text] [Related]  

  • 5. A mechanism of tolerance to the antihypertensive effect of ganglionic blocking agents in rats.
    Gardier RW; Peters JA
    Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):35-45. PubMed ID: 6144292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of decentralization and ganglionic blocking agents on the spontaneous release of H3-norepinephrine.
    HERTTING G; POTTER LT; AXELROD J
    J Pharmacol Exp Ther; 1962 Jun; 136():289-92. PubMed ID: 13906922
    [No Abstract]   [Full Text] [Related]  

  • 7. A DOUBLE blind control study of antihypertensive agents. I. Comparative effectiveness of reserpine, reserpine and hydralazine, and three ganglionic blocking agents, chlorisondamine, mecamyamine, and pentolinium tartrate.
    Arch Intern Med; 1960 Jul; 106():81-96. PubMed ID: 13856546
    [No Abstract]   [Full Text] [Related]  

  • 8. Laboratory observations on chlorisondamine (ecolid) and clinical results when used for the treatment of hypertension.
    DENNIS E; MOYER JH; STRAWN JR
    Am Pract Dig Treat; 1956 Nov; 7(11):1765-75. PubMed ID: 13362846
    [No Abstract]   [Full Text] [Related]  

  • 9. [EXPERIMENTAL RESEARCH ON THE INFLUENCE OF "TRASYLOL" AND "BIOSPEN" ON BURNS].
    D AMICO G; ZAPPALA L
    G Ital Chir; 1963 Sep; 19():543-65. PubMed ID: 14130555
    [No Abstract]   [Full Text] [Related]  

  • 10. Protective effect of ganglionic blocking agents on traumatic shock in the rat.
    ROSS CA; HERCZEG SA
    Proc Soc Exp Biol Med; 1956 Feb; 91(2):196-9. PubMed ID: 13297751
    [No Abstract]   [Full Text] [Related]  

  • 11. [Action of the ganglion blocking agent Ciba 9295 on the visceral injuries determined by a prolonged skin burn].
    ROMANI JD
    C R Seances Soc Biol Fil; 1952 Oct; 146(19-20):1511-5. PubMed ID: 13020231
    [No Abstract]   [Full Text] [Related]  

  • 12. Supersensitivity due to prolonged administration of ganglion-blocking compounds.
    EMMELIN N
    Br J Pharmacol Chemother; 1959 Jun; 14(2):229-33. PubMed ID: 13662579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EFFECT OF A TRYPSIN-INHIBITOR (TRASYLOL) IN EXPERIMENTAL PANCREATITIS.
    BERGENTZ SE; EDLUND Y
    Acta Chir Scand; 1964 Jun; 127():657-61. PubMed ID: 14175140
    [No Abstract]   [Full Text] [Related]  

  • 14. Ecolid: a new hypotensive agent.
    MAXWELL RD; HOWIE TJ
    Br Med J; 1955 Nov; 2(4949):1189-90. PubMed ID: 13269829
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of the ganglionic-blocking agent diochin on the motility of the stomach].
    TOLMACH DV
    Khimiia Meditsina; 1960; 15():107-13. PubMed ID: 13777253
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the pharmacology of a ganglion-blocking agent heptamine].
    KHARKEVICH TsA
    Farmakol Toksikol; 1961; 24():156-60. PubMed ID: 13755641
    [No Abstract]   [Full Text] [Related]  

  • 17. Potentiation of vasoactive drugs by ganglionic blocking agents.
    LUM BK; RASHLEIGH PL
    J Pharmacol Exp Ther; 1961 Apr; 132():13-8. PubMed ID: 13764245
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the mechanism of the ganglionic blocking action of novocaine].
    KHARKEVICH DA
    Fiziol Zh SSSR Im I M Sechenova; 1962 Aug; 48():960-6. PubMed ID: 14455588
    [No Abstract]   [Full Text] [Related]  

  • 19. Kallikrein inhibitors.
    Fritz H; Fink E; Truscheit E
    Fed Proc; 1979 Dec; 38(13):2753-9. PubMed ID: 315885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [On the effect of ganglionic blocking agents on synaptic conduction of nervous excitation in the sympathetic ganglia].
    KHARKEVICH DA
    Biull Eksp Biol Med; 1962 Jul; 54():38-42. PubMed ID: 14455586
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.